ENZON PHARMACEUTICALS INC | 8-A12G/A: Others
ENZON PHARMACEUTICALS INC | 8-K: Current report
ENZON PHARMACEUTICALS INC | 10-Q: Quarterly report
ENZON PHARMACEUTICALS INC | 10-K/A: Annual report (Amendment)
ENZON PHARMACEUTICALS INC | 10-K: Annual report
ENZON PHARMACEUTICALS INC | 8-K: Current report
ENZON PHARMACEUTICALS INC: Q3 2023 Earnings Report
ENZON PHARMACEUTICALS INC | 10-Q: Q2 2023 Earnings Report
ENZON PHARMACEUTICALS INC | 4: Statement of changes in beneficial ownership of securities-Director READ RANDOLPH C
ENZON PHARMACEUTICALS INC | 8-K: Current report
ENZON PHARMACEUTICALS INC | 10-Q: Q1 2023 Earnings Report
ENZON PHARMACEUTICALS INC | ARS: Annual Report to Security Holders
ENZON PHARMACEUTICALS INC | DEFA14A: Others
ENZON PHARMACEUTICALS INC | DEF 14A: Definitive proxy statements
ENZON PHARMACEUTICALS INC: FY2022 Annual Report
10-K | ENZON PHARMACEUTICALS, INC. (0000727510) (Filer)
ENZON PHARMACEUTICALS INC | 8-K: Current report
ENZON PHARMACEUTICALS INC | 10-Q: Q3 2022 Earnings Report
ENZON PHARMACEUTICALS INC | 10-Q: Q2 2022 Earnings Report
ENZON PHARMACEUTICALS INC | 3: Initial statement of beneficial ownership of securities-Director Firestone Jaffrey Adam
ENZON PHARMACEUTICALS INC | 8-K: Current report
No Data